Is the Link Between Vascular Disease and Dementia Risk Being Overlooked?

Synopsis
Key Takeaways
- Vascular dementia is a significant but often overlooked condition.
- New research links nano- and microplastics to cognitive decline.
- Understanding vascular dementia requires new models of categorization.
- Existing conditions like hypertension and diabetes are major risk factors.
- Current dementia treatment paradigms need revision based on new findings.
New Delhi, Sep 20 (NationPress) Vascular dementia, a form of cognitive decline stemming from diseases affecting the small blood vessels in the brain, is a prevalent issue. However, it has not received the same level of scrutiny as Alzheimer's disease, which is characterized by the accumulation of abnormal plaques and protein tangles in neural tissue, as per researchers.
A research team from the University of New Mexico has created a novel framework for defining and categorizing various types of vascular dementia, aiming to enhance understanding of the disease's diverse manifestations and to identify effective treatment options.
While conditions such as hypertension, atherosclerosis, and diabetes have been established as contributors to vascular dementia, other potential factors—including the recent identification of substantial amounts of nano- and microplastics in human brains—remain inadequately explored, according to Elaine Bearer, a professor at the university.
“We have been operating in the dark. The various vascular pathologies have not been thoroughly characterized, leaving us uncertain about our treatment approaches. Furthermore, the presence of nano- and microplastics was previously undetected,” she stated.
In a study published in the American Journal of Pathology, Bearer and her team discovered 10 distinct pathological processes that contribute to vascular-related brain injuries, primarily by inducing deficiencies in oxygen or nutrients, serum leakage, and inflammation or reduced waste removal. These factors lead to minor strokes that damage neurons.
She highlighted novel and existing experimental methods, including specialized stains and advanced microscopy techniques, to identify these issues.
Moreover, the emerging concern regarding the health implications of nano- and microplastics within the brain was emphasized by Bearer. “Nanoplastics in the brain introduce a new variable in brain pathology,” she remarked.
“All our current paradigms regarding Alzheimer's and other dementias must be reconsidered in light of this finding,” she added.
“My findings indicate a significantly higher concentration of plastics in individuals with dementia compared to those without. This seems to correlate with the severity and type of dementia,” she noted. The presence of plastics was also linked to increased inflammation levels.